# Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

> **NCT06481696** · NA · RECRUITING · sponsor: **Andros Day Surgery Clinic** · enrollment: 90 (estimated)

## Conditions studied

- Unexplained Infertility

## Interventions

- **DIETARY_SUPPLEMENT:** Resveratrol-based multivitamin supplement
- **DIETARY_SUPPLEMENT:** Folic acid
- **PROCEDURE:** IVF/ICSI
- **DRUG:** Follitropin Alfa
- **DRUG:** Ganirelix Acetate 0.5 MG/ML [Fyremadel]
- **DRUG:** hCG 10.000 IU or triptorelin 0,3 mg, subcutaneously

## Key facts

- **NCT ID:** NCT06481696
- **Lead sponsor:** Andros Day Surgery Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06481696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06481696, "Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06481696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*